Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III)
Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
ATPIII Guidelines:
> ATP III Executive Summary
This document summarizes the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III). The executive summary
contains treatment recommendations derived from the evidence-based full ATP III report. Key tables and figures from the full
report are included for easy reference.
Topics addressed in the executive summary include classification of lipids and lipoproteins, coronary heart disease (CHD)
risk assessment, lifestyle interventions, drug treatment, and interventions to improve adherence. Recommendations for special
populations such as patients with CHD, patients at high risk for developing CHD, patients with diabetes, women, older Americans,
young adults, and racial and ethnic groups are provided.
> ATP III Full Summary
The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) presents the NCEP's updated clinical guidelines for
holesterol testing and management. The ATP III full set of guidelines is an evidence-based, extensively referenced report that
is the basis for several related products and tools.
The ATP III guidelines provide detailed information on topic areas such as classification of lipids and lipoproteins, coronary
heart disease (CHD) risk assessment, lifestyle interventions, drug treatment, specific dyslipidemias, and adherence issues.
Recommendations for special populations such as patients with CHD, patients at high risk for developing CHD, patients with
diabetes, women, older Americans, young adults, and racial and ethnic groups are provided.
> ATP III Update 2004: Implications of Recent Clinical Trials
The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001 (Executive Summary published in JAMA, 2001;285:2486-2497). Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. The present document reviews the results of these recent trials and assesses their implications for cholesterol management.